Skip to content

Application of dexmedetomidine combined with sufentanil, tramadol and esketamine in PCIA after gynecological endoscopic surgery

Application of dexmedetomidine combined with sufentanil, tramadol and esketamine in PCIA after gynecological endoscopic surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050988
Enrollment
Unknown
Registered
2021-09-09
Start date
2021-09-30
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic endoscopic surgery

Interventions

DS group:opioid
DT group:Weak opioid
DE group: opioid free

Sponsors

The Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists (ASA) grades I-III; 2. Aged 19 to 65 years; able to use PCA pump proficiently; 3. Understand and fully cooperate with the use of postoperative scoring tools.

Exclusion criteria

Exclusion criteria: 1. Body mass index (BMI) > 30kg/m^2; 2. History of angina pectoris or myocardial infarction within the past 6 months; 3. Patients with poorly controlled or untreated hypertension (resting systolic/diastolic blood pressure >180/100mmHg); 4. Untreated or insufficiently treated patients with hyperthyroidism; 5. Patients with liver and kidney insufficiency; 6. Neuropsychiatric patients; 7. Long-term alcoholics; 8. Long-term use of sedative, hypnotic and analgesic drugs; 9. Heart rate < 50 beats/min or third degree atrioventricular block; 10. Known to be allergic to test drugs such as dexmedetomidine or/and esketamine; 11. Those who change the surgical method during the operation; 12. Loss of patient data during the perioperative period.

Design outcomes

Primary

MeasureTime frame
ponv;pain;Ramsay??;MMSE??;

Secondary

MeasureTime frame
Cumulative amount of analgesic medication used, total number of analgesic pump presses, additional medication after pain is still felt;vital signs;Other adverse reactions;Perioperative data (drug use, duration of operation, duration of anesthesia, recovery time, extubation time, time to discharge, etc.;

Countries

China

Contacts

Public ContactLi Xiaoxia

The Second Affiliated Hospital of Chongqing Medical University

lixiaoxia2002@126.com+86 13368380465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026